Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ICVX Icosavax > Detailed Quotes

ICVX Icosavax

3.060
-0.100-3.16%
Trading Session 10/03 12:45 ET
High
3.260
Open
3.250
Turnover
216.37K
Low
2.970
Pre Close
3.160
Volume
69.12K
Market Cap
122.05M
P/E(TTM)
Loss
52wk High
35.775
Shares
39.89M
P/E(Static)
Loss
52wk Low
2.960
Float Cap
65.58M
Bid/Ask %
85.37%
Historical High
49.990
Shs Float
21.43M
Volume Ratio
1.09
Historical Low
2.960
Dividend TTM
--
Div Yield TTM
--
P/B
0.50
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.32%
Amplitude
9.18%
Avg Price
3.130
Lot Size
1
Float Cap
65.58M
Bid/Ask %
85.37%
Historical High
49.990
Shs Float
21.43M
Volume Ratio
1.09
Historical Low
2.960
Dividend TTM
--
P/B
0.50
Dividend LFY
--
Turnover Ratio
0.32%
Amplitude
9.18%
Avg Price
3.130
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA.
CEO: Mr. Adam Simpson
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...